BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ONO-3310 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ONO-3310\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07619157-939@assetmemo.bio
DTSTAMP:20261121T005443Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:ONO-3310: Phase 1 readout est. (NCT07619157)
DESCRIPTION:ONO-3310\, phase 1\, Chronic Kidney Disease.\nStudy: A Study of
  ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patien
 ts With Type 2 Diabetes Mellitus\nEstimated primary completion: 30 Novembe
 r 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/ono-3310#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07619157
URL:https://assetmemo.bio/drug/ono-3310#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
